Results 1 to 10 of about 271,187 (352)

Factors related to dosing frequency and route of administration in methotrexate intolerance among patients with rheumatoid arthritis: a cross-sectional study. [PDF]

open access: yesTher Adv Drug Saf
Background: Methotrexate is central to the management of rheumatoid arthritis (RA). However, its use is often limited by methotrexate intolerance. Objectives: This study aims to explore the association between alternative methotrexate dosing methods and ...
Almalag HM   +9 more
europepmc   +2 more sources

Retrospective evaluation and prediction of clearance and toxicity of high dose methotrexate in childhood acute lymphoblastic leukemia patients

open access: yesBrazilian Journal of Pharmaceutical Sciences, 2021
To find the predictors of High Dose Methotrexate toxicities in childhood Acute Lymphoblastic Leukemia Patients. This study included 198 Childhood Acute Lymphoblastic Leukemia patients (303 infusions) who were treated with High Dose Methotrexate ...
Yuxia Shan   +6 more
doaj   +1 more source

Prevalence of methotrexate intolerance in juvenile idiopathic arthritis and possible risk factors: a tertiary center experience

open access: yesThe Journal of Pediatric Academy, 2022
Methotrexate that has a safe and inexpensive profile is a first choice of juvenile idiopathic arthritis treatment. Nevertheless, gastrointestinal symptoms are not serious but common side effects of methotrexate.
Zahide Ekici Tekin   +11 more
doaj   +1 more source

The effects of casticin and myricetin on liver damage induced by methotrexate in rats [PDF]

open access: yesIranian Journal of Basic Medical Sciences, 2018
Objective(s): In this study, we evaluated the therapeutic effects of casticin and myricetin on liver  damage induced by methotrexate in rats.Materials and Methods: Thirty-six male rats were used for the study and divided into 6 groups: control ...
Fazile Nur Eki̇nci̇-Akdemi̇r   +6 more
doaj   +1 more source

Harmine Has Nephroprotective Effect Against Methotrexate-Induced Injury in Mice via Inhibition of Oxidative Stress [PDF]

open access: yesResearch Journal of Pharmacognosy, 2021
Background and objectives: Despite clinical use, the efficacy of methotrexate is often limited by some adverse effects, mainly nephrotoxicity. The most common mechanism of methotrexate-induced kidney damages is oxidative stress.
Cyrus Jalili   +5 more
doaj   +1 more source

A Rare Case of Methotrexate Induced Pancreatitis in Ectopic Pregnancy

open access: yesThe Ewha Medical Journal, 2023
Ectopic pregnancy (EP) refers to blastocyst implantation outside the uterine endometrium. EP is major cause of maternal morbidity and mortality. Treatment options include surgery, medical therapy with methotrexate,
Jiwon Choi   +4 more
doaj   +1 more source

Effect of methotrexate on neurobehavior and cholinesterase in chicks [PDF]

open access: yesIraqi Journal of Veterinary Sciences, 2023
This reading aimed to determine the therapeutic index of methotrexate (MTX) with a note on the consequence of methotrexate in chicks on neurobehavioral in addition to calculating the activity for cholinesterase in plasma and brain in chicks.
Maab A. Fadel   +2 more
doaj   +1 more source

Polyglutamation of methotrexate. Is methotrexate a prodrug? [PDF]

open access: yesJournal of Clinical Investigation, 1985
La polyglutamation est assuree par la folyl polyglutamyl synthetase.
J Baram   +7 more
openaire   +3 more sources

Methotrexate in the urine [PDF]

open access: yesKidney International, 2011
A 62-year-old man with a recent diagnosis of primary central nervous system lymphoma developed acute kidney injury (AKI) after administration of high-dose methotrexate. AKI developed within 48 h of therapy despite prior infusion of intravenous bicarbonate solution. Serum methotrexate level was 2.61 μmol/l at 24 h and 0.25 μmol/l 72 h after methotrexate
Michael W. Ross, Sandeep K. Mallipattu
openaire   +3 more sources

Methotrexate and Pralatrexate [PDF]

open access: yesDermatologic Clinics, 2015
This article reviews methotrexate and the more potent, related compound, pralatrexate, for the treatment of cutaneous T-cell lymphomas, including mycosis fungoides, Sézary syndrome, and CD30+ lymphoproliferative disorders. Although these folate antagonists are traditionally viewed as antiproliferative cell cycle inhibitors, it is recognized that they ...
Jianqiang Wu, Gary S. Wood
openaire   +2 more sources

Home - About - Disclaimer - Privacy